pharma · Urothelial Carcinoma Bladder · Castration Resistant Metastatic Prostate Cancer · AKTS
Aktis Oncology
Aktis Oncology drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Cambridge, USA HQ
90 Employees
Public company Type
AKTS · NYSE Ticker
Company details
- Status
- Public
- HQ
- Cambridge, USA
- Employees
- 90
- Programs
- 2
- Drugs
- 0
- Patents
- 1
Aktis Oncology pipeline
Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Aktis Oncology drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.